-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$122.4232.33% Upside
Recent Analyst Forecasts and Stock Ratings
Axsome Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover Axsome Therapeutics, Inc.?
Axsome Therapeutics, Inc. has been rated by research analysts at Guggenheim, Mizuho Securities, Wells Fargo, H.C. Wainwright, Bank of America Securities, RBC Capital in the past 90 days.